Share-based legacy RSU program granted
08 Aprile 2024 - 11:58AM
Share-based legacy RSU program granted
Share-based legacy RSU program granted
Novonesis’ Board of Directors has following the
merger with Chr. Hansen Holding A/S (“Chr. Hansen”) today approved
the continuation in 2024 of a legacy Chr. Hansen annual short-term
incentive program comprising of up to 125,000 restricted share
units (RSUs) for around 130 legacy Chr. Hansen key employees below
the Executive Management level. Receipt of the RSUs is subject to
specified KPIs and criteria supporting performance and retention.
The KPIs include personal targets and financial performance
indicators (such as: sales revenue, adjusted EBITDA margin, and net
working capital in % of sales). Upon grant the RSUs will vest after
a period of two (2) years after which participants may receive one
(1) Novonesis B share per RSU. The value of the program is up to
€6.7m.
- 2024_12_Share-based_legacy_RSU_program_granted
Grafico Azioni Novonesis AS (TG:NZM2)
Storico
Da Nov 2024 a Dic 2024
Grafico Azioni Novonesis AS (TG:NZM2)
Storico
Da Dic 2023 a Dic 2024
